"The Sidney Kimmel Center for Prostate and Urologic Cancers, located on 353 East 68th Street, New York, NY, provides state-of-the-art care to men with prostate, urologic, and other genitourinary cancers. For general information, call Memorial Sloan Kettering at 212-639-2000, 24 hours a day, seven days a week. To make an appointment, call us at 833-494-2758, Monday through Friday between 8:00 AM and 6:00 PM ET."

During the past decade, Memorial Sloan-Kettering Cancer Center, Sidney Kimmel Center conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Memorial Sloan-Kettering Cancer Center, Sidney Kimmel Center" #1 collaborator was "Astellas Pharma Inc" with 1 trials as a collaborator, "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 1 trials as a collaborator and "Seagen Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Memorial Sloan-Kettering Cancer Center, Sidney Kimmel Center" are "Prostate Cancer" (2 trials), "Bladder Cancer" (1 trials), "Cancer of the Prostate" (1 trials), "Hormone Sensitive Prostate Cancer" (1 trials) and "Kidney Neoplasms" (1 trials). Many other conditions were trialed in "Memorial Sloan-Kettering Cancer Center, Sidney Kimmel Center" in a lesser frequency.

Most popular intervention types in "Memorial Sloan-Kettering Cancer Center, Sidney Kimmel Center" are "Drug" (5 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Axitinib (AG-013736)" (2 trials), "Avelumab (MSB0010718C)" (1 trials), "Docetaxel" (1 trials), "Enfortumab Vedotin" (1 trials) and "Enzalutamide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Memorial Sloan-Kettering Cancer Center, Sidney Kimmel Center" are 3 trials for "All" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Memorial Sloan-Kettering Cancer Center, Sidney Kimmel Center". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Memorial Sloan-Kettering Cancer Center, Sidney Kimmel Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Memorial Sloan-Kettering Cancer Center, Sidney Kimmel Center, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".